中國信達(01359.HK)再追討潘蘇通等74億人幣 獲內地法院受理
中國信達(01359.HK)公布,與信風投資及廣東高銀設立的合夥企業已向內地法院向起訴高銀金融(00530.HK)大股東潘蘇通、高銀金控、高銀天津、松日資訊等,追討其承擔尚未償還的本金74億元人民幣(下同)及利息、罰息、複利等還款義務,其中已獲得勝訴判決的15億元申索部分不再起訴。
松日資訊及潘蘇通承擔未償債務擔保義務,合夥企業有權就高銀天津名下部分地塊建築物及建設用地使用權、廣州鑫富大(現更名為廣州富大)100%股權及松日資訊100%股權折價或就拍賣、變賣所得價款優先受償。
法院已受理該訴訟。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.